WallStreetZenWallStreetZen

NYSE: VAPO
Vapotherm Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for VAPO

Based on 2 analysts offering 12 month price targets for Vapotherm Inc.
Min Forecast
$2.00+48.15%
Avg Forecast
$3.50+159.26%
Max Forecast
$5.00+270.37%

Should I buy or sell VAPO stock?

Based on 4 analysts offering ratings for Vapotherm Inc.
Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
3 analysts 75%
Sell
0 analysts 0%
Strong Sell
1 analysts 25%

Be the first to know when Wall Street analysts revise their VAPO stock forecasts and price targets.

VAPO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
BTIG
Top 5%
96
HoldDowngradesN/AN/A2022-08-04
Piper Sandler
Top 15%
86
Strong SellMaintains$2.00+48.15%2022-08-04
William Blair
Bottom 10%
10
HoldDowngradesN/AN/A2022-08-04
Canaccord Genuity
Bottom 10%
10
HoldDowngrades$5.00+270.37%2022-05-06

1 of 1

Forecast return on equity

Is VAPO forecast to generate an efficient return?

Forecast return on assets

Is VAPO forecast to generate an efficient return on assets?
Company
-27.03%
Industry
10.37%
VAPO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VAPO earnings per share forecast

What is VAPO's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$2.13
Avg 2 year Forecast
-$1.14

VAPO revenue forecast

What is VAPO's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$89.2M+26.77%
Avg 2 year Forecast
$101.9M+44.81%
VAPO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VAPO revenue growth forecast

How is VAPO forecast to perform vs Medical Devices companies and vs the US market?
Company
26.77%
Industry
10.11%
Market
71.5%
VAPO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VAPO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VAPO vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
VAPO$1.35$3.50+159.26%Sell
IRIX$2.25$3.00+33.33%Hold
BSGM$0.74$4.00+440.54%Strong Buy
POCI$6.12N/AN/A
TLIS$0.59$1.25+111.15%Strong Sell
View Top Medical Device Stocks

Vapotherm Stock Forecast FAQ

Is Vapotherm Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: VAPO) stock is to Sell VAPO stock.

Out of 4 analysts, 0 (0%) are recommending VAPO as a Strong Buy, 0 (0%) are recommending VAPO as a Buy, 3 (75%) are recommending VAPO as a Hold, 0 (0%) are recommending VAPO as a Sell, and 1 (25%) are recommending VAPO as a Strong Sell.

If you're new to stock investing, here's how to buy Vapotherm stock.

What is VAPO's earnings growth forecast for 2023-2024?

(NYSE: VAPO) Vapotherm's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 91.65%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 85.4%.

Vapotherm's earnings in 2023 is -$110,382,000.On average, 2 Wall Street analysts forecast VAPO's earnings for 2023 to be -$56,883,620, with the lowest VAPO earnings forecast at -$58,218,917, and the highest VAPO earnings forecast at -$55,281,265.

In 2024, VAPO is forecast to generate -$30,444,755 in earnings, with the lowest earnings forecast at -$30,444,755 and the highest earnings forecast at -$30,444,755.

What is VAPO's revenue growth forecast for 2023-2024?

(NYSE: VAPO) Vapotherm's forecast annual revenue growth rate of 26.77% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 71.5%.

Vapotherm's revenue in 2023 is $70,382,000.On average, 2 Wall Street analysts forecast VAPO's revenue for 2023 to be $2,382,702,629, with the lowest VAPO revenue forecast at $2,343,177,860, and the highest VAPO revenue forecast at $2,422,227,398.

In 2024, VAPO is forecast to generate $2,721,867,876 in revenue, with the lowest revenue forecast at $2,721,867,876 and the highest revenue forecast at $2,721,867,876.

What is VAPO's forecast return on assets (ROA) for 2023-2024?

(NYSE: VAPO) forecast ROA is -27.03%, which is lower than the forecast US Medical Devices industry average of 10.37%.

What is VAPO's Price Target?

According to 2 Wall Street analysts that have issued a 1 year VAPO price target, the average VAPO price target is $3.50, with the highest VAPO stock price forecast at $5.00 and the lowest VAPO stock price forecast at $2.00.

On average, Wall Street analysts predict that Vapotherm's share price could reach $3.50 by Aug 4, 2023. The average Vapotherm stock price prediction forecasts a potential upside of 159.26% from the current VAPO share price of $1.35.

What is VAPO's Earnings Per Share (EPS) forecast for 2023-2024?

(NYSE: VAPO) Vapotherm's current Earnings Per Share (EPS) is -$4.18. On average, analysts forecast that VAPO's EPS will be -$2.13 for 2023, with the lowest EPS forecast at -$2.18, and the highest EPS forecast at -$2.07. In 2024, VAPO's EPS is forecast to hit -$1.14 (min: -$1.14, max: -$1.14).

What is VAPO's forecast return on equity (ROE) for 2023-2024?

(NYSE: VAPO) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.